Cargando…

Life after COVID-19: R WE going to help?

Detalles Bibliográficos
Autores principales:	Ramagopalan, Sreeram V, Wasiak, Radek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319494/ https://www.ncbi.nlm.nih.gov/pubmed/32390452 http://dx.doi.org/10.2217/cer-2020-0056

Ejemplares similares

Real-world data in the United Kingdom: opportunities and challenges
por: McDonald, Laura, et al.
Publicado: (2016)

Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study
por: Ramagopalan, Sreeram, et al.
Publicado: (2014)

Time to really share real-world data?
por: Graham, Sophie, et al.
Publicado: (2018)

Multiple sclerosis: major histocompatibility complexity and antigen presentation
por: Ramagopalan, Sreeram V, et al.
Publicado: (2009)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Can real-world data really replace randomised clinical trials?
por: Ramagopalan, Sreeram V., et al.
Publicado: (2020)

A review of data sharing statements in observational studies published in the BMJ: A cross-sectional study
por: McDonald, Laura, et al.
Publicado: (2017)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
por: Simpson, Alex, et al.
Publicado: (2022)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12
por: Bray, Ben, et al.
Publicado: (2023)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11
por: Bray, Ben, et al.
Publicado: (2023)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13
por: Bray, Benjamin D, et al.
Publicado: (2023)

Forward We Go!
por: Nezhat, Farr R., et al.
Publicado: (2023)

COVID-19: What we need from epidemiology to help informed policies
por: Wong, Xin Ci, et al.
Publicado: (2021)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Commentary: Cardiac surgery in COVID patients: Figuring it out as we go
por: Clark, Sarah A., et al.
Publicado: (2021)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Should we go nuts about nuts?
por: Rohrmann, Sabine, et al.
Publicado: (2013)

Predicting Molecular Models: Where Are We Going?
por: Ratta, Raffaele, et al.
Publicado: (2015)

Virtually learning as we go: Reflections on medical education through COVID-19
por: Boyd, Kerry, et al.
Publicado: (2020)

Commentary: COVID-19—How it has impacted ophthalmic care and where do we go from here?
por: Gupta, Vivek, et al.
Publicado: (2020)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data
por: Wilkinson, Samantha, et al.
Publicado: (2021)

Hemofiltration in sepsis: where do we go from here?
por: Kellum , John A, et al.
Publicado: (2000)

Implementation of Outpatient Total Joint Arthroplasty in Canada: Where We are and Where We Need to Go
por: Zomar, Bryn O, et al.
Publicado: (2020)

All bleeding stops: how we can help...
por: Riordan, William P, et al.
Publicado: (2010)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

COVID-19 and ethics: We learn as we go. But where are we going?
por: Le Dorze, Matthieu, et al.
Publicado: (2021)

Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?
por: Krammer, Florian
Publicado: (2020)

The Anthropocene, global change and sleeping giants: where on Earth are we going?
por: Steffen, Will
Publicado: (2006)

Exploring the Promise of Resveratrol: Where Do We Go From Here?
por: Crandall, Jill P., et al.
Publicado: (2013)

Ultra-protective tidal volume: how low should we go?
por: Costa, Eduardo LV, et al.
Publicado: (2013)

Self-tracking the microbiome: where do we go from here?
por: Gimbert, Carine, et al.
Publicado: (2015)

Dermatology education in skin of colour: where we are and where do we go?
por: Onasanya, Joshua, et al.
Publicado: (2021)

BMI Guidelines for Bariatric Surgery in Diabetes: How Low Can We Go?
por: Ryan, Donna H.
Publicado: (2012)

Commentary: Care for retinopathy of prematurity in the COVID-19 era: When the going gets tough, the tough get going
por: Sen, Parveen, et al.
Publicado: (2022)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Prioritizing sexual and reproductive health in the face of competing health needs: where are we going?
por: Otu, Akaninyene, et al.
Publicado: (2021)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Evidence-based guidelines for bleeding in trauma patients: where do we go from here?
por: Minei, Joseph P
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hbkm2nkm3fhgpqjrimks515fdr